{"AllianceGenome": "19372", "HGNC": "19372", "MIM": "609509", "_id": "386653", "_version": 1, "accession": {"genomic": ["AB253489.1", "AC048338.29", "CH471054.1", "CP068266.2", "CS398406.1", "CS399446.1", "CS401255.1", "CS456685.1", "CS720082.1", "FB507079.1", "FB753876.1", "GM989492.1", "GN088750.1", "HC731045.1", "HH829734.1", "JC449282.1", "JC485840.1", "NC_000012.12", "NC_060936.1"], "protein": ["AAI32999.1", "AAI33001.1", "AAS86448.1", "CAL44872.1", "CAL44939.1", "CAL44950.1", "CAL91842.1", "CAP40193.1", "CAT05434.1", "CAV32859.1", "CAX21673.1", "CAX86999.1", "CBL94048.1", "CBX32717.1", "CDM63719.1", "CEF37136.1", "EAW98310.1", "NP_001014358.1", "Q6EBC2.1"], "rna": ["AY499343.1", "BC132998.1", "BC133000.1", "NM_001014336.2"], "translation": [{"protein": "AAI32999.1", "rna": "BC132998.1"}, {"protein": "NP_001014358.1", "rna": "NM_001014336.2"}, {"protein": "AAS86448.1", "rna": "AY499343.1"}, {"protein": "AAI33001.1", "rna": "BC133000.1"}]}, "alias": "IL-31", "ensembl": {"gene": "ENSG00000204671", "protein": "ENSP00000366234", "transcript": "ENST00000377035", "translation": [{"protein": "ENSP00000366234", "rna": "ENST00000377035"}], "type_of_gene": "protein_coding"}, "entrezgene": "386653", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.7078543, "exp_mis": 64.136975, "exp_syn": 33.1405585, "lof_z": 1.53736118014405, "mis_z": 0.985563132710424, "mu_lof": 3.9280530712e-07, "mu_mis": 5.54973780904e-06, "mu_syn": 2.81400548153e-06, "n_lof": 2.0, "n_mis": 48.0, "n_syn": 38.0, "p_li": 0.150887238101552, "p_null": 0.071839234946305, "p_rec": 0.777273526952143, "syn_z": -0.523306057859824}, "bp": 495, "cds_end": 122658719, "cds_start": 122656958, "n_exons": 3, "nonpsych": {"exp_lof": 5.1042522, "exp_mis": 57.9882463, "exp_syn": 29.9334961, "lof_z": 1.34940700426067, "mis_z": 0.860284983722483, "mu_lof": 3.9280530712e-07, "mu_mis": 5.54973780904e-06, "mu_syn": 2.81400548153e-06, "n_lof": 2.0, "n_mis": 45.0, "n_syn": 35.0, "p_li": 0.135872832236038, "p_null": 0.0982392165842568, "p_rec": 0.765887951179706, "syn_z": -0.583032537365494}, "nontcga": {"exp_lof": 5.24519187, "exp_mis": 58.999987, "exp_syn": 30.48328029, "lof_z": 1.39778679579842, "mis_z": 1.10263675262126, "mu_lof": 3.9280530712e-07, "mu_mis": 5.54973780904e-06, "mu_syn": 2.81400548153e-06, "n_lof": 2.0, "n_mis": 42.0, "n_syn": 34.0, "p_li": 0.132701824147556, "p_null": 0.087025734767115, "p_rec": 0.780272441085329, "syn_z": -0.40330094981477}, "transcript": "ENST00000377035.1"}, "exons": [{"cdsend": 122174172, "cdsstart": 122172411, "chr": "12", "position": [[122172028, 122172741], [122173843, 122173992], [122174156, 122174221]], "strand": -1, "transcript": "NM_001014336", "txend": 122174221, "txstart": 122172028}], "exons_hg19": [{"cdsend": 122658719, "cdsstart": 122656958, "chr": "12", "position": [[122656575, 122657288], [122658390, 122658539], [122658703, 122658768]], "strand": -1, "transcript": "NM_001014336", "txend": 122658768, "txstart": 122656575}], "generif": [{"pubmed": 15925362, "text": "Findings suggest that IL-31 may participate in the cause of itch sensation and promote scratching behavior in NC/Nga mice with atopic dermatitis."}, {"pubmed": 16461142, "text": "Significantly upregulated in pruritic atopic dermatitis. These findings provide a new link among staphylococcal colonization, subsequent T-cell recruitment/activation, and pruritus induction in patients with atopic dermatitis."}, {"pubmed": 16461143, "text": "IL-31 expression is associated with CLA(+) T cells and might contribute to the development of atopic dermatitis-induced skin inflammation and pruritus"}, {"pubmed": 17487427, "text": "IL-31 is a potent inducer of proinflammatory mediators in human colonic SEMFs. IL-31 may function as a proinflammatory cytokine derived from Th2 cells."}, {"pubmed": 17900679, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17900679, "text": "This study presents the first genetic risk factor for the nonatopic type of eczema and indicates a primary role of IL-31-induced pruritus in the initiation of this disease."}, {"pubmed": 18439099, "text": "The data suggest that increased IL-31Ralpha expression correlates with an enhanced response to IL-31."}, {"pubmed": 18678344, "text": "serum IL-31 levels were significantly higher in patients with atopic dermatitis (AD) compared with control subjects; findings provide evidence that IL-31 has a role in AD pathophysiology with regard to pruritus and skin inflammation"}, {"pubmed": 18802341, "text": "overexpressed in patients with atopic dermatitis; staphylococcal superantigens induce expression in atopic individuals"}, {"pubmed": 18839421, "text": "unlike eczema, genetic variation at COL29A1 and IL31 loci is unlikely to implact inflammatory bowel disease risk"}, {"pubmed": 18926762, "text": "IL-31 acts on a broad range of immune- & non-immune cells & possesses potential pleiotropic physiological functions, including regulating hematopoiesis & immune response, causing inflammatory bowel disease, airway hypersensitivity & dermatitis[review]"}, {"pubmed": 19281909, "text": "Human CD4(+) T cells express a functional H(4)R. The receptor is upregulated under T(H)2 conditions, and its stimulation leads to induction of AP-1 and IL-31."}, {"pubmed": 19889120, "text": "regulation of the IL-31 receptor and pro-inflammatory functions of IL-31 in human monocytes and monocyte-derived cells"}, {"pubmed": 19920145, "text": "IL-31 recognizes its receptor complex through two different binding sites"}, {"pubmed": 20163453, "text": "IL-31 serum levels may play a role in the pathophysiology of chronic spontaneous urticaria."}, {"pubmed": 20190140, "text": "The ability of beta-defensins and cathelicidin LL-37 to stimulate the production and release of IL-31 by human mast cells provides a novel mechanism by which skin-derived antimicrobial peptides/proteins may contribute to inflammatory reactions"}, {"pubmed": 20410259, "text": "induces pro-inflammatory cytokines and atopic dermatitis-related chemokines in eosinophils"}, {"pubmed": 21057749, "text": "Letter: polymorphisms in the IL-31 gene do not appear to underlie epidermolysis bullosa pruriginosa."}, {"pubmed": 21057749, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21182835, "text": "Data not only illustrate various functions that cysteines perform during IL-31 biosynthesis and secretion, but also highlight their potential roles in cytokine effector functions."}, {"pubmed": 21211659, "text": "IL-31 displays a unique and independent role in the pathophysiology of allergic rhinitis"}, {"pubmed": 21261663, "text": "Our findings show a functional role of IL-31 in human primary keratinocytes and provide a new link between TLR-2 ligands and IL-31 which might be dysregulated in atopic dermatitis."}, {"pubmed": 21294778, "text": "IL-31 is important in atopic dermatitis pathophysiology."}, {"pubmed": 21952721, "text": "IL-31-631 T>G polymorphism was significantly associated with IL-31 blood level but not with disease susceptibility."}, {"pubmed": 22017185, "text": "Distinct SPINK5 and IL-31 gene variants (SNPs) were associated with the development of atopic eczema and non-atopic hand dermatitis in Taiwanese nurses."}, {"pubmed": 22177328, "text": "This study suggests that IL-31 is an important regulator of keratinocyte differentiation and demonstrates a link between the presence of IL-31 in skin, as found in patients with atopic dermatitis, and filaggrin expression"}, {"pubmed": 22509760, "text": "IL-31 serum levels correlate with the SCORAD score, sleeplessness, and Th2 cytokines including IL-4 and IL-13, in sixty children with the extrinsic type of atopic dermatitis."}, {"pubmed": 22539792, "text": "IL-31-specific activation of dendritic cells may be part of a positive feedback loop driving the progression of inflammatory skin diseases."}, {"pubmed": 22621183, "text": "T cells in chronic atopic dermatitis (AD) skin produce IL-31 and AD lesions contain increased levels of these IL-31-producing T cells."}, {"pubmed": 22827739, "text": "hypothesize that an altered regulation of IL-31 gene expression influence clinical course of AD. The available published data and our results lend support to an important role of IL-31 gene polymorphism in AD pathogenesis"}, {"pubmed": 23392388, "text": "IL-31 and IL-31RA are upregulated in patients with allergic rhinitis, and induce MUC5AC gene expression in human airway epithelial cells."}, {"pubmed": 23621408, "text": "IL-31 induces pro-inflammatory effects in activated human macrophages via STAT-1 and 5 phosphorylation. Interleukin-31-induced ERK 1/2 activation contributes to the underlying mechanism of Th1 cytokine IL-12 suppression in macrophages."}, {"pubmed": 23694808, "text": "Il-31 is not a TH2 cytokine in the classical sense but is likely to be expressed by a number of cells in an allergic situation in which IL-4 is present and possibly contribute to the allergic reaction."}, {"pubmed": 23698099, "text": "CD4+CD26- malignant cells specifically produce IL-31 and clinical resolution of pruritus correlates with decreased IL-31 levels in the circulation"}, {"pubmed": 23794184, "text": "EGFR-TK inhibitors could cause keratinocytes injury, the release of IL-33 and the consequent interaction with its receptor on mast cells, that induces the secretion of several factors capable to cause skin manifestations, included IL-31"}, {"pubmed": 23874436, "text": "IL-31 seems to be another sweat stimulator."}, {"pubmed": 24515918, "text": "enhanced Th2 cytokine levels was correlated with IL-31 expression in NPs and provide a possible explanation for IL-31's regulatory role in the pathogenesis of NPs."}, {"pubmed": 24573820, "text": "Case Report: sporadic lichen amyloidosis with high expression of Il31."}, {"pubmed": 24667097, "text": "IL-31-positive cells were observed as mononuclear infiltrating cells and as CD11b co-expressing cells in severe atopic dermatitis samples."}, {"pubmed": 24943220, "text": "Data show that STAT6 and NF-kappaB are central players in mediating IL-31 expression induced by IL-4/IL-33."}, {"pubmed": 24984931, "text": "TARC and interleukin-31 may be biomarkers for adult atopic dermatitis"}, {"pubmed": 25122210, "text": "IL-31 was increased after IVIG treatment in patients with KD and was significantly associated with CAL formation."}, {"pubmed": 25176053, "text": "The IL-31 serum level was significantly higher in cutaneous T-cell lymphoma patients than in the control group but there were no positive correlation between IL-31 serum level and pruritus."}, {"pubmed": 25270263, "text": "IL-31 may play an important role in the pathophysiology of uremic pruritus."}, {"pubmed": 25283844, "text": "The interleukin IL-31/IL-31receptor axis contributes to tumor growth in human follicular lymphoma."}, {"pubmed": 25285475, "text": "IL-31 expression in allergic rhinitis aggravated and amplified Th2 inflammation as well as mucin production"}, {"pubmed": 25488078, "text": "The results of our analyses regarding serum levels and receptor expression do not suggest a central role of IL-31 in Mycosis fungoides/Sezary syndrome pathogenesis."}, {"pubmed": 25534405, "text": "The results of this study suggest that the severity of atopic dermatitis in a Polish population is associated with some specific haplotypes of the IL-31 gene and renew questions concerning the role of IL-31 in pruritus in atopic dermatitis."}, {"pubmed": 25572240, "text": "the results suggest that IL-31 may be a candidate gene associated with the pathogenesis of rheumatoid arthritis"}, {"pubmed": 25710085, "text": "In summary, TGF-beta1 and IL-31 were linked to progression from chronic hepatitis B to liver cirrhosis, and correlated well with the severity of disease."}, {"pubmed": 25756056, "text": "IL-31 is overexpressed in the lesional skin of LP but its expression does not correlate with intensity of pruritus."}, {"pubmed": 26198770, "text": "Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology."}, {"pubmed": 26306032, "text": "crucial requirements for IL-31 signaling and its counter-regulation by SOCS3"}, {"pubmed": 26316486, "text": "In a CML patient with pruritus receiving imatinib mesylate, IL-31 and IL-33 serum levels were significantly higher than controls. Imatinib could cause keratinocyte injury, the release of IL-33, and the consequent interaction with its receptor on mast cells, inducing IL-31 secretion.  The IL-31/IL-33 axis may be involved in the pathogenesis of skin side effects related to imatinib mesylate treatment."}, {"pubmed": 26357000, "text": "a possible systemic involvement of IL-31 and the absence of a systemic involvement of IL-33 in allergic contact dermatitis."}, {"pubmed": 26449657, "text": "An increase of IL-31 serum levels in postmenopausal women with decreased bone mineral density, is shown."}, {"pubmed": 26769434, "text": "Suggest that IL-31 gene may play a role in the development of systemic lupus erythematosus."}, {"pubmed": 26853551, "text": "both SCF and IL-31 play an important role in mediating inflammation and enhancing severity of atopic asthma."}, {"pubmed": 26864868, "text": "Serum/pleural fluid IL-31 levels are elevated in tuberculous pleural effusion."}, {"pubmed": 26944931, "text": "IL-31 affects keratinocyte differentiation in multiple ways and the IL-1 cytokine network is a major downstream effector of IL-31 signaling in deregulating the physical skin barrier."}, {"pubmed": 27152943, "text": "While serum TSLP levels were unaffected by concomitant allergies and atopic comorbidities, serum levels of IL-31, IL-33 and sST2 were affected to a small extent. We found a positive correlation between TSLP, IL-31 and IL-33, and an inverse relationship between IL-33 and sST2"}, {"pubmed": 27276346, "text": "Distinct polymorphic variants of the IL-31 gene may be involved in the patho-genesis of mastocytosis, and IL-31 may be involved in the induction of pruritus in patients with mastocytosis."}, {"pubmed": 27340318, "text": "High IL31 expression is associated with Endometrial Cancer."}, {"pubmed": 27663978, "text": "This study indicated that CXCL13 rather than IL-31 may have clinical values of diagnosis and prognosis in hepatocellular carcinoma."}, {"pubmed": 28147314, "text": "IL31 and its receptor, IL31RA, are highly expressed in various human and mouse cancer cell lines, as well as in tumor specimens from cancer patients. MC38 murine colon carcinoma cells depleted of IL31 exhibit an increase in invasive and migratory properties in vitro."}, {"pubmed": 28303765, "text": "this study shows that IL-31 may be involved in the pathogenesis of asthma and rhinitis; dust mite and mugwort allergy could increase it significantly"}, {"pubmed": 28408397, "text": "The first demonstration of the involvement of the IL-31/IL-31R axis in cancer came from studies in patients with mycosis fungoides/Sezary syndrome, the most frequent, cutaneous T cell lymphoma. Tumor cells were shown to produce IL-31, whose serum levels correlated with pruritus intensity."}, {"pubmed": 28465041, "text": "Serum IL-31 levels and IL-31+ cells infiltration in the skin lesions was significantly higher in in the dermatitis herpetiformis (DH) and bullous pemphigoid (BP) groups than in healthy subjects. High amounts of IL-31 in the skin as well as peripheral blood might contribute to the persistent occurrence of itch in patients with DH and BP."}, {"pubmed": 28572699, "text": "IL-31 gene polymorphisms were tightly associated with dilated cardiomyopathy susceptibility and contributed to worse prognosis in DCM patients."}, {"pubmed": 28808661, "text": "Obtained results, as well as literature data, show that lower concentration of IL-31 in patients' serum may be correlated with its role in JAK/STAT signaling pathway which is involved in development of autoimmune blistering disease"}, {"pubmed": 28823642, "text": "Study showed increased IL-31 levels in serum and blister fluid of bullous pemphigoid patients, indicating a pathophysiological role for IL-31 in this autoimmune blistering disease."}, {"pubmed": 29046191, "text": "review: in-depth overview of the role of IL-31 in chronic skin diseases and the possible diagnostic and therapeutic applications in the management of these diseases"}, {"pubmed": 29050818, "text": "this study shows that decreased serum levels of IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis"}, {"pubmed": 29116431, "text": "IL-31 polymorphisms may be significant risk factors for bladder cancer, and the single nucleotide polymorphism rs4758680 could be an independent risk factor for the decreased recurrence-free survival of muscle-invasive bladder cancer patients."}, {"pubmed": 29259273, "text": "Higher plasma levels of IL-17, IL-31, and IL-33 among CSU patients."}, {"pubmed": 29366565, "text": "The available data show that IL-31 is strongly linked with chronic pruritic skin disorders, such as atopic eczema, and represents a novel target for directed drug therapy."}, {"pubmed": 29427643, "text": "IL-31 enhances BNP release."}, {"pubmed": 29484036, "text": "The findings suggest that rs7977932 and rs4758680 of IL-31 may be associated with the development and progression of the epithelial ovarian cancer in the Chinese population."}, {"pubmed": 29490771, "text": "these findings provide evidence that IL-33 induced secretion of IL-31 from LAD2 mast cells"}, {"pubmed": 29494763, "text": "In patients with itchy dermatomyositis, gene expression of IL31 and IL31RA in lesional skin was upregulated compared with nonlesional skin and healthy control skin. IL31 mRNA expression positively correlated with visual analogue scale itch score. On immunofluorescence, immunoreactivity for IL-31 and IL-31RA was stronger in lesional skin."}, {"pubmed": 29693698, "text": "Eosinophils are a major source of IL-31 in bullous pemphigoid and this cytokine may contribute to itch in these patients."}, {"pubmed": 29769586, "text": "Decrease In Il-31 Serum Levels Is Associated With increased Structural Damage In Early Axial Spondyloarthritis."}, {"pubmed": 29791232, "text": "Lung cancer patients homozygous CC for rs7977932 or carried the G allele of rs4758680 had significantly poorer prognoses compared to those who did not have these genotype; the rs7977932 CC genotype was significantly associated with metastasis and poor survival status in lung adenocarcinoma"}, {"pubmed": 30423602, "text": "These findings suggest that IL-31 produced by mast cells in response to Porphyromonas gingivalis infection causes gingival epithelial barrier dysfunction, which may contribute to the chronic inflammation observed in periodontitis."}, {"pubmed": 31049931, "text": "CD11b(+) cells markedly express the itch cytokine interleukin-31 in polymorphic light eruption."}, {"pubmed": 31145337, "text": "Results demonstrated that IL-31 gene polymorphisms were associated with the genetic susceptibility to cryptorchidism in a Chinese population. Compared with CC genotype, the A carriers (CA/AA genotypes) of rs4758680 were protect factors in cryptorchidism susceptibility."}, {"pubmed": 31766607, "text": "This paper aims to give the readers a complete and updated review of IL-31 and IL-33 involvement among the most common autoimmune and allergic disorders."}, {"pubmed": 32069819, "text": "IL-33/IL-31 Axis in Osteoporosis."}, {"pubmed": 32305780, "text": "Interleukin-31 interaction with inflammasome: A promising diagnostic and prognostic panel for early sepsis identification in critically ill patients."}, {"pubmed": 32459958, "text": "Feline Interleukin-31 Shares Overlapping Epitopes with the Oncostatin M Receptor and IL-31RA."}, {"pubmed": 32531145, "text": "Increased expression of in situ IL-31RA and circulating CXCL8 and CCL2 in pemphigus herpetiformis suggests participation of the IL-31 family in the pathogenesis of the disease."}, {"pubmed": 32705506, "text": "Regulation of pro-opiomelanocortin (POMC) gene transcription by interleukin-31 via early growth response 1 (EGR-1) in HaCaT keratinocytes."}, {"pubmed": 32843492, "text": "IL-31 induces antitumor immunity in breast carcinoma."}, {"pubmed": 33130460, "text": "Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder."}, {"pubmed": 33559859, "text": "Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor Microenvironment."}, {"pubmed": 34443554, "text": "The Novel Role of MIF in the Secretion of IL-25, IL-31, and IL-33 from PBMC of Patients with Rheumatoid Arthritis."}, {"pubmed": 34491348, "text": "The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development."}, {"pubmed": 34642338, "text": "Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis."}, {"pubmed": 35274883, "text": "The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases."}, {"pubmed": 35324695, "text": "The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect?"}, {"pubmed": 36651089, "text": "IL-31 and IL-31 receptor alpha in pemphigus: Contributors to more than just itch?"}, {"pubmed": 37815092, "text": "Possible Association of Interleukin-31/-31RA Signalling and Basophils with Itch in Porokeratosis."}, {"pubmed": 37888922, "text": "Targeting Interleukin-31 in Prurigo."}, {"pubmed": 38084871, "text": "Mechanism underlying pruritus in recessive dystrophic epidermolysis bullosa: Role of interleukin-31 from mast cells and macrophages."}, {"pubmed": 38088514, "text": "The IL-31/CysLT2R axis is associated with itching in patients with allergic rhinitis."}, {"pubmed": 38301356, "text": "Increased tissue expression of IL-31 in patients with psoriasis."}], "genomic_pos": {"chr": "12", "end": 122174221, "ensemblgene": "ENSG00000204671", "start": 122172029, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 122658746, "start": 122656577, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0002376", "qualifier": "involved_in", "term": "immune system process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007165", "qualifier": "involved_in", "term": "signal transduction"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 21182835, "qualifier": "located_in", "term": "extracellular space"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005125", "qualifier": "enables", "term": "cytokine activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005126", "qualifier": "enables", "term": "cytokine receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[9544, 701655], [9598, 744097], [9606, 386653], [9615, 100302725]], "id": 88541}, "interpro": {"desc": "Interleukin-31", "id": "IPR027987", "short_desc": "IL-31"}, "ipi": "IPI00455213", "map_location": "12q24.31", "name": "interleukin 31", "other_names": "interleukin-31", "pantherdb": {"HGNC": "19372", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1923649", "ortholog_type": "LDO", "panther_family": "PTHR38652", "taxid": 10090, "uniprot_kb": "Q6EAL8"}, {"Ensembl": "ENSRNOG00000026192", "ortholog_type": "LDO", "panther_family": "PTHR38652", "taxid": 10116, "uniprot_kb": "D3ZIP0"}], "uniprot_kb": "Q6EBC2"}, "pathway": {"kegg": {"id": "hsa04060", "name": "Cytokine-cytokine receptor interaction - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-6783589", "name": "Interleukin-6 family signaling"}, {"id": "R-HSA-6788467", "name": "IL-6-type cytokine receptor ligand interactions"}]}, "pfam": "PF15209", "pharmgkb": "PA134957950", "pharos": {"target_id": 11893, "tdl": "Tbio"}, "reagent": {"CondMedia_CM_LibrAB": {"id": "GNF293313", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF337094", "relationship": "is"}}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1"], "protein": "NP_001014358.1", "rna": "NM_001014336.2", "translation": {"protein": "NP_001014358.1", "rna": "NM_001014336.2"}}, "reporter": {"GNF1H": "gnf1h21604_at", "HTA-2_0": "TC12002070.hg.1", "HuEx-1_0": "3475496", "HuGene-1_1": "7967226", "HuGene-2_1": "16771627"}, "summary": "IL31, which is made principally by activated Th2-type T cells, interacts with a heterodimeric receptor consisting of IL31RA (MIM 609510) and OSMR (MIM 601743) that is constitutively expressed on epithelial cells and keratinocytes. IL31 may be involved in the promotion of allergic skin disorders and in regulating other allergic diseases, such as asthma (Dillon et al., 2004 [PubMed 15184896]).[supplied by OMIM, Mar 2008].", "symbol": "IL31", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1426200"}, "unigene": "Hs.569071", "uniprot": {"Swiss-Prot": "Q6EBC2"}, "wikipedia": {"url_stub": "Interleukin 31"}}